Showing results (11-20 of 308) with videos related to
Sort By:
Pageof 31
Reviews on Recent Clinical Trials|May 14, 2008
The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancerAnthony HowellBest Practice & Research. Clinical Endocrinology & Metabolism|October 31, 2008
The endocrine prevention of breast cancerAnthony HowellBMC Medicine|November 18, 2010
Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?Anthony HowellBehavioral Sciences (Basel, Switzerland)|January 21, 2017
Potential Benefits and Harms of Intermittent Energy Restriction and Intermittent Fasting Amongst Obese, Overweight and Normal Weight Subjects-A Narrative Review of Human and Animal EvidenceMichelle Harvie, Anthony HowellBreast Cancer Research : BCR|November 13, 2004
Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogensAnthony Howell, Mitch DowsettCancer Treatment Reviews|October 4, 2005
Clinical development of fulvestrant ("Faslodex")Anthony Howell, Paul AbramThe Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Are aromatase inhibitors superior to antiestrogens?Anthony Howell, Aman BuzdarThe Journal of Steroid Biochemistry and Molecular Biology|June 7, 2005
Vascular effects of aromatase inhibitors: data from clinical trialsAnthony Howell, Jack CuzickExpert Review of Anticancer Therapy|July 13, 2002
Fulvestrant (Faslodex): current status in the therapy of breast cancerNigel Bundred, Anthony HowellThe Proceedings of the Nutrition Society|March 15, 2012
Energy restriction and the prevention of breast cancerMichelle Harvie, Anthony HowellPageof 31